N-Acetyl Transferase Genotypes in Relation to Risk of Developing Systemic Lupus Erythematosus

Journal of Rheumatology

Volumn 31, Issue 1, 2004, Pages 76-80

  Cooper, Glinda S ^a   Treadwell, Edward L ^c   Dooley, Mary Anne ^b   St Clair, E William ^d   Gilkeson, Gary S ^e   Taylor, Jack A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Arylamines; Autoimmune disease n acetyl transferase metabolism; Systemic lupus erythematosus; Tobacco

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE; HAIR DYE; N ACYLTRANSFERASE 1; N ACYLTRANSFERASE 2; UNCLASSIFIED DRUG;

ACETYLATION; ACETYLATOR PHENOTYPE; ALLELE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAIR COLOR; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

ADULT; ARYLAMINE N-ACETYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAIR DYES; HUMANS; ISOENZYMES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREVALENCE; RISK FACTORS;

EID: 0346057901     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomark Prev 2000;9:29-42.
2. Cribb AE, Grant DM, Miller MA, Spielberg SP. Expression of monomorphic arylamine N-acetyl transferase (NAT1) in human leukocytes. J Pharmacol Exp Ther 1991;259:1241-6.
3. Sieben S, Kawakubo Y, Sacs B, Al Masaoudi T, Merk HF, Blömeke B. T cell responses to paraphenylenediamine and to its metabolites mono- and diacetyl-paraphenylenediamine. Int Arch Allerg Immunol 2001;124:356-8.
4. Bruhn C, Brockmöller J, Cascorbi I, Roots I, Borchert H. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1). Biochem Pharmacol 1999;58:1759-64.
5. Kadlubar FF, Badawi AF. Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. Toxicol Lett 1995;82:627-32.
6. Uetrecht JP, Woosley RL. Acetylator phenotype and lupus erythematosus. Clin Pharmacokinet 1981;6:118-34.
7. Adams LE, Hess EV. Drug-related lupus. Incidence, mechanisms and clinical implications. Drug Saf 1991;6:431-49.
8. Reidenberg MM, Drayer DE, Lorenzo B, et al. Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum 1993;36:971-3.
9. Zschieschang P, Hiepe F, Gromnica-Ihle E, Roots I, Cascorbi I. Lack of association between arylamine N-acetyltranserase 2 (NAT2) polymorphism and systemic lupus erythematosus. Pharmacogenetics 2002;12:559-63.
10. von Schmiedeberg S, Fritsche E, Ronnau AC, et al. Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus eryrhematosus. Adv Exp Med Biol 1999;455:147-52.
11. Cooper GS, Dooley MA, Treadwell EL, St. Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: Results of a population-based, case-control study. Arthritis Rheum 2002;46:1830-9.
12. Cooper GS, Dooley MA, Treadwell EL, St. Clair EW, Gilkeson GS. Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. J Rheumatol 2001;12:2653-6.
13. Cooper GS, Parks CG, Treadwell EL, et al. Differences by race, sex, and age in the clinical and immunologic features of recently-diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 2002;11:161-7.
14. Ward MM, Studenski S. Systemic lupus erythematosus in men: A multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990;17:220-4.
15. Olshan AF, Weissler MC, Watson MA, Bell DA. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2000;9:185-91.